U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H23N3O
Molecular Weight 297.3947
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ACETERGAMINE

SMILES

CN1C[C@H](CNC(C)=O)C[C@H]2[C@H]1CC3=CNC4=C3C2=CC=C4

InChI

InChIKey=SGZVEWGAZGOWGP-XGWLTEMNSA-N
InChI=1S/C18H23N3O/c1-11(22)19-8-12-6-15-14-4-3-5-16-18(14)13(9-20-16)7-17(15)21(2)10-12/h3-5,9,12,15,17,20H,6-8,10H2,1-2H3,(H,19,22)/t12-,15+,17+/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H23N3O
Molecular Weight 297.3947
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Acetergamine is a derivative of ergoline, it is an oxytocic agent. Acetergamine is alpha-1 blocker and vasodilator. It has been investigated as a treatment for cerebellar ataxia.

Approval Year

PubMed

Sample Use Guides

In Vivo Use Guide
LD50 40 mg/kg i.v. rabbit
Route of Administration: Intravenous
Substance Class Chemical
Record UNII
O60O0JB93O
Record Status Validated (UNII)
Record Version